Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Iannitto

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Case Reports in Hematology|September 3, 2014
Two cases of q-Fever in hairy cell leukemiaEmanuele Ammatuna, Emilio Iannitto, Lidwine W Tick, et al.
Journal of Gastroenterology and Hepatology|August 9, 2002
Are blood donors an adequate control group to ascertain HCV prevalence in non-Hodgkin's lymphoma patientsEmilio Iannitto, Stefano De Cantis, Sonia Cirrincione, et al.
Nature Reviews. Clinical Oncology|November 11, 2009
Gamma-delta T-cell lymphomasClaudio Tripodo, Emilio Iannitto, Ada Maria Florena, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2009
Evaluating the risk of hepatitis B reactivation in patients with haematological malignancies: is the serum hepatitis B virus profile reliable?Donatella Ferraro, Paola Pizzillo, Vito Di Marco, et al.
European Journal of Haematology|July 8, 2005
Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytesEmilio Iannitto, Viviana Minardi, Giuseppina Calvaruso, et al.
Hematological Oncology|January 25, 2012
Tumour burden predicts treatment resistance in patients with early unfavourable or advanced stage Hodgkin lymphoma treated with ABVD and radiotherapyPaolo G Gobbi, Emilio Bassi, Manuela Bergonzi, et al.
Expert Review of Hematology|September 3, 2013
Treatment of elderly patients with chronic lymphocytic leukemia: an unmet cinical needStefano Molica, Maura Brugiatelli, Fortunato Morabito, et al.
Cancer Chemotherapy and Pharmacology|February 17, 2009
Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphomaGaetano Corazzelli, Gaetana Capobianco, Manuela Arcamone, et al.
Digestive Diseases and Sciences|August 20, 2003
Screening for celiac disease in non-Hodgkin's lymphoma patients: a serum anti-transglutaminase-based approachAntonio Carroccio, Emilio Iannitto, Lidia Di Prima, et al.
Haematologica|November 26, 2008
CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosisClaudio Tripodo, Andrea Di Bernardo, Maria Paola Ternullo, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Case Reports in Hematology|September 3, 2014
Two cases of q-Fever in hairy cell leukemiaEmanuele Ammatuna, Emilio Iannitto, Lidwine W Tick, et al.
Journal of Gastroenterology and Hepatology|August 9, 2002
Are blood donors an adequate control group to ascertain HCV prevalence in non-Hodgkin's lymphoma patientsEmilio Iannitto, Stefano De Cantis, Sonia Cirrincione, et al.
Nature Reviews. Clinical Oncology|November 11, 2009
Gamma-delta T-cell lymphomasClaudio Tripodo, Emilio Iannitto, Ada Maria Florena, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2009
Evaluating the risk of hepatitis B reactivation in patients with haematological malignancies: is the serum hepatitis B virus profile reliable?Donatella Ferraro, Paola Pizzillo, Vito Di Marco, et al.
European Journal of Haematology|July 8, 2005
Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytesEmilio Iannitto, Viviana Minardi, Giuseppina Calvaruso, et al.
Hematological Oncology|January 25, 2012
Tumour burden predicts treatment resistance in patients with early unfavourable or advanced stage Hodgkin lymphoma treated with ABVD and radiotherapyPaolo G Gobbi, Emilio Bassi, Manuela Bergonzi, et al.
Expert Review of Hematology|September 3, 2013
Treatment of elderly patients with chronic lymphocytic leukemia: an unmet cinical needStefano Molica, Maura Brugiatelli, Fortunato Morabito, et al.
Cancer Chemotherapy and Pharmacology|February 17, 2009
Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphomaGaetano Corazzelli, Gaetana Capobianco, Manuela Arcamone, et al.
Digestive Diseases and Sciences|August 20, 2003
Screening for celiac disease in non-Hodgkin's lymphoma patients: a serum anti-transglutaminase-based approachAntonio Carroccio, Emilio Iannitto, Lidia Di Prima, et al.
Haematologica|November 26, 2008
CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosisClaudio Tripodo, Andrea Di Bernardo, Maria Paola Ternullo, et al.
Pageof 7